Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. Swiss HIV Cohort Study
Published in
AIDS, vol. 11, no. 12, p. F95-99Publication date
1997Abstract
Keywords
- Acquired Immunodeficiency Syndrome/blood/ drug therapy
- Anti-HIV Agents/adverse effects/pharmacokinetics/ therapeutic use
- CD4 Lymphocyte Count
- CD4-CD8 Ratio
- Cohort Studies
- Drug Resistance, Microbial
- Drug Therapy, Combination
- Female
- HIV Protease/ genetics
- HIV Protease Inhibitors/adverse effects/pharmacokinetics/ therapeutic use
- Humans
- Male
- Mutation
- Pilot Projects
- Ritonavir/adverse effects/pharmacokinetics/ therapeutic use
- Saquinavir/adverse effects/pharmacokinetics/ therapeutic use
- Viremia/drug therapy
UNIGE affiliation entities
Citation (ISO format)
LORENZI, P. et al. Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. Swiss HIV Cohort Study. In: AIDS, 1997, vol. 11, n° 12, p. F95–99. doi: 10.1097/00002030-199712000-00002
Main files (1)
Article
Identifiers
- PID : unige:7419
- DOI : 10.1097/00002030-199712000-00002
- PMID : 9342060
